International Journal of Cancer Management

Published by: Kowsar

A Report of Delayed Toxicities of Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma: A Single Center Cross-sectional Study

Afshin Rakhsha 1 , Samira Azghandi 1 , Ahmad Ameri 2 , Amir Shahram Yousefi Kashi 1 , Saeed Karimi 3 , Saranaz Azari-Marhabi 4 and Farzad Taghizadeh-Hesary ORCID 1 , *
Authors Information
1 Department of Radiation-Oncology, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Emam Hossein Educational Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Ophthalmic Research Center, Torfeh Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • International Journal of Cancer Management: 12 (5); e91606
  • Published Online: May 14, 2019
  • Article Type: Research Article
  • Received: March 15, 2019
  • Revised: April 16, 2019
  • Accepted: May 5, 2019
  • DOI: 10.5812/ijcm.91606

To Cite: Rakhsha A, Azghandi S, Ameri A, Yousefi Kashi A S, Karimi S, et al. A Report of Delayed Toxicities of Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma: A Single Center Cross-sectional Study, Int J Cancer Manag. Online ahead of Print ; 12(5):e91606. doi: 10.5812/ijcm.91606.

Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Safavi A, Raad N, Raad N, Ghorbani J. Epidemiology of nasopharyngeal cancers in Iran: A 6-year Report. Asian Pac J Cancer Prev. 2015;16(10):4447-50. doi: 10.7314/APJCP.2015.16.10.4447. [PubMed: 26028112].
  • 2. Gordin A, Golz A, Daitzchman M, Keidar Z, Bar-Shalom R, Kuten A, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: Diagnostic accuracy and impact on clinical management. Int J Radiat Oncol Biol Phys. 2007;68(2):370-6. doi: 10.1016/j.ijrobp.2006.12.028. [PubMed: 17324532].
  • 3. Lee N, Pfister DG, Garden A. A phase II study of concurrent chemoradiotherapy using 3-D conformal radiotherapy (3D-CRT) or intensity-modulated radiation therapy (IMRT) + bevacizumab (BV) for locally or regionally advanced nasopharyngeal cancer. Radiation Therapy Oncology Group; 2006.
  • 4. Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: Radiation therapy oncology group phase II trial 0225. J Clin Oncol. 2009;27(22):3684-90. doi: 10.1200/JCO.2008.19.9109. [PubMed: 19564532]. [PubMed Central: PMC2720082].
  • 5. Ferrell B, Coyle N. Textbook of palliative nursing. United State: Oxford University Press; 2006.
  • 6. Mornex F, Pavy JJ, Denekamp J, Bolla M. [Scoring system of late effects of radiations on normal tissues: The SOMA-LENT scale]. Cancer Radiother. 1997;1(6):622-68. French. doi: 10.1016/S1278-3218(97)82941-1. [PubMed: 9614880].
  • 7. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31(5):1341-6. doi: 10.1016/0360-3016(95)00060-C. [PubMed: 7713792].
  • 8. Heintze U, Birkhed D, Bjorn H. Secretion rate and buffer effect of resting and stimulated whole saliva as a function of age and sex. Swed Dent J. 1983;7(6):227-38. [PubMed: 6583873].
  • 9. Mathers CD, Lopez AD, Murray CJL. The burden of disease and mortality by condition: Data, methods, and results for 2001. In: Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL, editors. Global Burden of Disease and Risk Factors. Washington (DC); 2006. eng.
  • 10. Margolis RH, Saly GL. Asymmetric hearing loss: Definition, validation, and prevalence. Otol Neurotol. 2008;29(4):422-31. doi: 10.1097/MAO.0b013e31816c7c09. [PubMed: 18418281].
  • 11. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. Cancer incidence in five continents, Volume IX. IARC Press, International Agency for Research on Cancer; 2007.
  • 12. Thompson L. World Health Organization classification of tumours: Pathology and genetics of head and neck tumours. Ear Nose Throat J. 2006;85(2):74. [PubMed: 16579185].
  • 13. Bucci M, Xia P, Lee N, Fishbein N, Kramer A, Weinberg V, et al. Intensity modulated radiation therapy for carcinoma of the nasopharynx: An update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2004;60(1):S317-8. doi: 10.1016/j.ijrobp.2004.07.130.
  • 14. Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL, Zelefsky MJ. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys. 2006;64(1):57-62. doi: 10.1016/j.ijrobp.2005.03.057. [PubMed: 15936155].
  • 15. Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004;60(5):1440-50. doi: 10.1016/j.ijrobp.2004.05.022. [PubMed: 15590175].
  • 16. Kwong DL, Pow EH, Sham JS, McMillan AS, Leung LH, Leung WK, et al. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: A prospective study on disease control and preservation of salivary function. Cancer. 2004;101(7):1584-93. doi: 10.1002/cncr.20552. [PubMed: 15378492].
  • 17. Hajisafari A, Bakhshandeh M, Aghamiri SMR, Houshyari M, Rakhsha A, Bolokat ER, et al. Prospective evaluation of the early effects of radiation on the auditory system frequencies of patients with head and neck cancers and brain tumors after radiotherapy. Ear Nose Throat J. 2018;97(3):E10-7. doi: 10.1177/014556131809700302. [PubMed: 29554405].
  • 18. Lee N, Xia P, Quivey JM, Sultanem K, Poon I, Akazawa C, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002;53(1):12-22. doi: 10.1016/S0360-3016(02)02724-4. [PubMed: 12007936].
  • 19. Lee AW, Ng WT, Hung WM, Choi CW, Tung R, Ling YH, et al. Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors. Int J Radiat Oncol Biol Phys. 2009;73(4):1121-8. doi: 10.1016/j.ijrobp.2008.05.023. [PubMed: 18723296].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments